DIVIDEND ANNOUNCEMENT: Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 09/02/2020 declared a dividend of $0.1500 per share

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) on 09/02/2020 declared a dividend of $ 0.1500 per share payable on September 30, 2020 to shareholders of record as of September 15, 2020. Dividend amount recorded is an increase of $ 0.15 from last dividend Paid.

Ord Cl A/Royalty Pharma plc (NASDAQ:RPRX) has paid dividends since 1970, has a current dividend yield of 1.4423078299% and has increased its dividends for 0 successive years.

Ord Cl A/Royalty Pharma plc's market cap is $ 15,221,398,400 and has a PE ratio of 0.00. The stock price closed yesterday at $ 41.60 and has a 52 week low/high of $ 39.90 and $ 56.50.

Royalty Pharma is a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Co.'s portfolio includes royalties on more than 45 commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta, and Vertex's Kalydeco, Symdeko and Trikafta, and three development-stage product candidates.

For more information on Ord Cl A/Royalty Pharma plc click here.